NEW YORK, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of JE, ABMD, and CURLF. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you take no action, you may remain an absent class member.
To discuss the cases below please contact Matthew E. Guarnero toll free at (877) 779-1414.
Curaleaf Holdings (OTC BB: CURLF)
CLASS PERIOD: 11/21/2018 - 07/22/2019
LEAD PLAINTIFF DEADLINE: October 04, 2019
Throughout the class period Defendants made false and/or misleading statements and/or failed to disclose that: (i) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (ii) Curaleaf also sold unapproved animal drugs on its website; (iii) such conduct would result in a warning letter from the U.S. Food and Drug Administration (“FDA”); and (iv) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To get additional information about the CURLF Shareholder Class Action Lawsuit contact Matthew E. Guarnero toll free at (877) 779-1414
Just Energy Group Inc. (NYSE: JE)
CLASS PERIOD: 11/09/2017 - 07/23/2019
LEAD PLAINTIFF DEADLINE: September 30, 2019
Throughout the class period, Defendants made material misstatements or omissions that: (1) the Company experienced customer enrollment and nonpayment issues; (2) as a result, the Company was reasonably likely to incur an impairment charge to its accounts receivable; (3) as a result, the Company lacked adequate internal control over its financial reporting; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To get additional information about the JE Shareholder Class Action Lawsuit contact Matthew E. Guarnero
ABIOMED Inc. (NASDAQ: ABMD)
CLASS PERIOD: 01/31/2019 - 07/31/2019
LEAD PLAINTIFF DEADLINE: October 7, 2019
Throughout the Class Period, Defendants made material misstatements and/or failed to disclose that: (i) Abiomed’s revenue growth was in decline; (ii) the Company did not have a sufficient plan in place to stem its declining revenue growth; (iii) the Company was unlikely to restore its revenue growth over the next several fiscal quarters; (iv) consequently, Abiomed was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company’s prior projections and market expectations; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.
To get additional information about the ABMD Shareholder Class Action Lawsuit contact Matthew E. Guarnero toll free at (877) 779-1414
Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.
ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information
Matthew E. Guarnero
Bernstein Liebhard LLP
http://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com